About
Cardicell is developing a self-care medical device in the cardiac tele-medicine field for detecting life-threatening diseases. The company's current product is designed to enable prompt analysis of heart attacks by means of a tiny personal device that can bebe used by the general population for preliminary diagnosis of chest pains. Cardicell's core technology utilizes a signal-acquisition method enabling wireless detection of cardiac abnormalities. This technology (along with a user-friendly interface) is what enables thecardio-electric device to accurately and instantly detect heart attacks, requiring no prior medical knowledge. In this way, detection of heart attacks can be done instantaneously by anyone, anywhere, and at anytime.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Cardicell's primary focus in the medical device field?
- Cardicell is developing a self-care medical device in the cardiac tele-medicine field for detecting life-threatening diseases, specifically focusing on prompt analysis of heart attacks.
- What is the core technology behind Cardicell's product?
- Cardicell's core technology utilizes a signal-acquisition method that enables wireless detection of cardiac abnormalities.
- What is the status of Cardicell as of November 2016?
- Cardicell has been inactive since November 2016, according to startupim data.
- When was Cardicell founded?
- Cardicell was founded in January 2006.
- Where is Cardicell's headquarters located?
- Cardicell's headquarters is located in Ra'anana, Center District, Israel.
- What is Cardicell's current product stage?
- Cardicell's product is in the R&D stage.
- How many employees does Cardicell have?
- Cardicell has 6 employees.
- Who is a founder of Cardicell?
- Lior Berkner is a founder of Cardicell.